To evaluate time‐related variations of neuroendocrine and immune system components (GH‐IGF1 axis, hypothalamus–pituitary–thyroid axis, melatonin, cortisol, lymphocyte subsets and IL2) in lung cancer patients compared to healthy controls. Here, IL2 is linked to lung cancer.